Walleye Capital’s iShares Biotechnology ETF IBB Stock Holding History

Walleye Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$609K	Buy	+3,202	New	+$550K	﹤0.01%	2546
2026 Q1	–	Sell	-15,097	Closed	-$2.55M	–	4656
2025 Q4	$2.55M	Buy	+15,097	New	+$2.45M	0.01%	1676
2025 Q3	–	Sell	-4,655	Closed	-$589K	–	4784
2025 Q2	$589K	Buy	4,655 +985	+27%	+$121K	﹤0.01%	2497
2025 Q1	$469K	Sell	3,670 -4,588	-56%	-$622K	﹤0.01%	2617
2024 Q4	$1.09M	Sell	8,258 -760	-8%	-$107K	﹤0.01%	2308
2024 Q3	$1.31M	Buy	9,018 +4,082	+83%	+$591K	﹤0.01%	2355
2024 Q2	$678K	Sell	4,936 -4,064	-45%	-$543K	﹤0.01%	3227
2024 Q1	$1.23M	Buy	9,000 +6,301	+233%	+$861K	﹤0.01%	2387
2023 Q4	$367K	Buy	+2,699	New	+$329K	﹤0.01%	3196

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Walleye Capital's IBB Position: Q2 2026 in Review

Walleye Capital opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 3,202 shares worth $609K. The stake represents ﹤0.01% of the portfolio and ranks #2546 among its holdings. This is a return to the name: Walleye Capital previously reported a position in IBB as recently as Q4 2025.

Walleye Capital first reported a position in IBB in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.55M in Q4 2025. 957 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Walleye Capital held 3,202 shares of iShares Biotechnology ETF worth $609K as of Q2 2026.
iShares Biotechnology ETF was a new Walleye Capital position in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2546 holding.
Walleye Capital first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 9 quarters since.
Walleye Capital's iShares Biotechnology ETF position peaked at $2.55M in Q4 2025.
957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.